Procter & Gamble is Accelerating Revenue Growth as its Costs are Rising
Procter & Gamble is Accelerating Revenue Growth as its Costs are Rising The Globe and Mail
Covered in this story
Analyst targets on Procter & Gamble
- UBS: $159 → $172 by Oct 2027 · Buy via GuruFocus
- RBC Capital Markets: $148 → $166 by Oct 2027 via MarketBeat
- Evercore ISI: $150 → $166 by Oct 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PG yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Procter & Gamble →Dalsna Finance is currently tracking 38 stories mentioning Procter & Gamble, the earliest published 31 Aug 2026.
Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.